NICOLE WEEDMAN: Open Payments
NPI 1821615337 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,610 in 112 payments from 34 companies in 2025. Trend: 2023 $1,632 · 2024 $1,914 · 2025 $2,610
Food & beverage: $2,339Education: $271
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $450 |
| SEAGEN INC. | 3 | $271 |
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Janssen Biotech, Inc. | 8 | $186 |
| ARRAY BIOPHARMA INC | 5 | $116 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Celgene Corporation | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
Products named: XTANDI, ELREXFIO, KEYTRUDA, KISQALI, Enhertu, IBRANCE, REBLOZYL, TAGRISSO.
Industry payments across NE — which companies pay providers there.
